medigraphic.com
ISSN 1729-519X (Print)

2020, Number 2

<< Back Next >>

Revista Habanera de Ciencias Médicas 2020; 19 (2)

Drug-resistant epilepsy. Experience with surgical treatment at the Institute of Neurology and Neurosurgery, Havana, Cuba (2012-2018)

Riascos LJH, Dearriba RMU, Castillo LGE, Lara FGE, Zarrabeitia OLE

Language: Spanish
References: 34
Page: 1-14
PDF size: 908.69 Kb.


ABSTRACT

Introduction: Epilepsy is the most frequent neurological alteration in the general population. The objective of epilepsy surgery is to guarantee the absence or the decrease of seizures which is achieved in 67 % and 80 % of patients.
Objective: To evaluate the surgical outcome and the factors for good outcome in patients with drug-resistant epilepsy (DRE) who underwent surgical treatment at the Institute of Neurology and Neurosurgery.
Material and Methods: A retrospective prospective observational study was conducted at the Institute of Neurology and Neurosurgery between January 2012 and May 2018.
Results: Of all the patients studied, 44,8 % were between 21 and 30 years old, 62,1 % were male and 82,8 % were white. Also, 31 % were between 11 and 20 years of follow-up. Epilepsy was lesional in 75,9 % of patients whereas in 55,2 % of them it was located in the temporal lobe; clinical congruence was demonstrated in 86,2 % of patients. Resective techniques were used in 87,6 % of them. Besides, 82,8 % had no postoperative seizures. There were no complications in 62,1 % of patients. On the other hand, 55 and 82 % of the patients studied were classified as Engel Class I and Engel Class II at 3, 6 and 12 months after surgical intervention.
Conclusions: The use of resective techniques and the absence of seizures after surgery predominated in our study. No significant relationship was found between surgical outcome, etiology of epilepsy and clinical congruence. The presence of a focal lesion of the temporal lobe was a factor for good outcome.


REFERENCES

  1. Trescher WH, Lesser RP. Epilepsias. En: Bradley WG, Daroff RB, Fenichel GM, Jankovic J, editors. Neurología clínica. 6ta ed. Madrid: Elsevier; 2015; 1939-76.

  2. Morales L. Epilepsias fármacorresistentes: su tratamiento en Cuba [Internet]. La Habana: Editorial Ciencias Médicas; 2017 [citado 08/02/2018]. Disponible en: http://bvs.sld.cu/libros/epilepsias_farmacorresistent es/indice_p.htm

  3. Placencia M. Incidencia, prevalencia y magnitud global de las epilepsias en América Latina y el Caribe. En: Campos MG y Kanner AM (Eds). Epilepsias: Diagnóstico y Tratamiento. Montevideo: Mediterráneo;2014. p. 49-68.

  4. García Bautista VG. Desempeño de la clínica de cirugía de epilepsia. [Tesis de maestría]. Ciudad de Guatemala: Universidad de San Carlos de Guatemala; 2015 [citado 05/08/ 2018]. Disponible en: http://biblioteca.usac.edu.gt/tesis/05/05_9757.pdf

  5. Carlson C, Dugan P, Kirsch HE, Friedman D. Sex differences in seizure types and symptoms. Epilepsy Behav 2014; 41:103-8.

  6. Freire ID, Valencia C, Ruiz N, Villamizar I, Freire IA. Resultados de cirugía de epilepsia en la Fundación Cardiovascular de Colombia: serie de casos. Acta Neurol Colomb [Internet] 2016 [citado 05/08/ 2018]; 32(2):108-14. Disponible en: http://www.scielo.org.co/scielo.php?script=sci_artte xt&pid=S0120-87482016000200004&lng=en

  7. Jobst B, Cascino G. Resective epilepsy surgery for drug-resistant focal epilepsy. JAMA 2015; 313(3):285- 93.

  8. Oficina Nacional De Estadística e Información. El Color de la Piel según el Censo de Población y Viviendas de 2012 [Internet]. La Habana: Centro de Estudios de Población y Desarrollo; 2016 [citado 08/08/ 2018]. Disponible en : http://www.one.cu/publicaciones/cepde/cpv2012/el colordelapielcenso2012/PUBLICACIÓNCOMPLETAcol ordelapiel.pdf

  9. Marcheco-Teruel B, Parra EJ, Fuentes-Smith E, Salas A, Buttenschøn HN, et al. Cuba: Exploring the History of Admixture and the Genetic Basis of Pigmentation Using Autosomal and Uniparental Markers. PLoS Genet [Internet]. 2014 [citado 08/08/ 2018]; 10(7):e1004488. Disponible en: http://dx.plos.org/10.1371/journal.pgen.1004488

  10. Berg AT, Kelly MM. Defining intractability: comparisons among published definitions. Epilepsia 2006; 47(2):431-6.

  11. Atehortúa M, Suarez J. Clinical characterization and cognitive profile before and after surgery for drug- resistant epilepsy. Acta Neurológica Colombiana 2011; 23:133-42.

  12. Morales Chacón LM. Evaluación neurofuncional en pacientes con epilepsia del lóbulo temporal candidatos a cirugía. [Tesis doctoral]. La Habana: Instituto Superior de Ciencias Médicas de La Habana; 2004 [citado 05/08/ 2018]. Disponible en: https://www.redalyc.org/articulo.oa?id=1812205400 10

  13. Jutila L. Surgical treatment of refractory temporal lobe epilepsy: Predictorsoflong-termoutcome. [Dissertation]. Finlandia: University of Eastern Finland; 2016.

  14. Sanabria Castro A, Henríquez Varela F, Lara Maier S, Monge Bonilla C, Sittenfeld Appel M. Caracterización de los pacientes con epilepsia refractaria de un hospital de tercer nivel en Costa Rica. Rev Neurol [Internet]. 2016 [citado 05/08/ 2018]; 63(2):58-64. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/27377981

  15. Jiménez Torres MJ, Aliaga Rocabado M, Torrejón López R. Recurrencia de crisis epilépticas posttratamiento quirúrgico para cirugía epilepsia en el servicio de Neurocirugía del Hospital Materno Infantil. Rev Med La Paz 2014; 20(2):15-22.

  16. Barreto Acevedo E, Villafuerte Espinoza M, Becerra Zegarra A, Díaz Vásquez A, Hernández Vizarreta J, et al. Cirugía resectiva de epilepsia lesional focal: estudio en pacientes adultos del Seguro Social del Perú. Rev Neuropsiquiatr 2017; 80(1):12-21.

  17. Torres Díaz CV. Papel de la resonancia magnética en la cirugía resectiva de la epilepsia resistente. [Tesis doctoral]. Madrid: Universidad Autónoma de Madrid; 2015. [citado 08/08/ 2018].Disponible en: http://hdl.handle.net/10486/9883

  18. Mohan M, Keller S, Nicolson A, Biswas S, Smith D, Osman Farah J, et al. The long-term outcomes of epilepsy surgery. PLoS ONE 2018; 13(5): e0196274.

  19. Arcos Algaba AN. Estimulación del nervio vago, una alternativa en el tratamiento de la epilepsia refractaria. [Tesis doctoral]. Galicia: Universidad de Santiago de Compostela; 2015 [citado 08/082018]. Disponible en: https://minerva.usc.es/xmlui/bitstream/handle/103 47/2818/9788498874242_content.pdf;jsessionid=2F 9D9D66E0A0646BE1979D9A46F3E735?sequence=1

  20. Roessler K, Hofmann A, Sommer B, Grummich P, Coras R, Kasper BS, et al. Resective neuronavigation: the Erlangen experience of 415 patients. Neurosurg Focus 2016; 40(3):E15.

  21. Lau T, Miller T, Klein T, Benbadis SR, Vale FL. Temporal lobe surgery in medically refractory epilepsy: a comparison between populations based on MRI findings. Seizure 2014; 23:20-4.

  22. Palmini A. Epilepsy surgery in countries with limited resources. In: Simon Shorvon, editor. The treatment of epilepsy. 4th ed. [Internet]. Blackwell: Willey; 2014; 1051-6. [citado 08/08/2018]. Disponible en : http://doi.wiley.com/10.1002/9781118936979.ch81

  23. Scaramelli A, Martínez Collette C, Braga P, Bogacz A, Duce S, Ruggia R, et al. Cirugía de epilepsia. Experiencia en el Hospital de Clínicas de Montevideo. Rev Med Uruguay [Internet]. 2016 [citado 08/08/2018]; 22:36-45. Disponible en: http://www.scielo.edu.uy/scielo.php?script=sci_artt ext&pid=S1688-03902006000100006&lng=es

  24. Zaroff CM, Morrison C, Ferraris N, Weiner HL, Miles DK, Devinsky O. Developmental outcome of epilepsy surgery in tuberous sclerosis complex. Epileptic Disorders 2015; 7:321-6.

  25. Acevedo H, Zambrano E, Olivares O, Taha L, Taha Y. Resultados de callosotomía en adultos con diagnóstico de epilepsia refractaria y drop-attack. Rev Chil Neuro-Psiquiat 2015; 53(2): 86-92.

  26. Mikati MA, Ataya N, El-Ferezli J, Shamseddine A, Rahi A, Herlopian A, et al. Epilepsy surgery in a developing country (Lebanon): Ten years’ experience and predictors of outcome. Epileptic Disord 2012; 14:267-74.

  27. Bender del Busto JE, Morales Chacón L, Bouza Molina W, García Maeso I, García Navarro ME. Algunos aspectos de la pre evaluación quirúrgica en el paciente con epilepsia refractaria. Rev Mex Neuroci [Internet]. 2004 [citado 08/08/2018]; 5(4):335-43. Disponible en : http://previous.revmexneurociencia.com/articulo/al gunos-aspectos-de-la-preevaluacion-quirurgica-enel- paciente-con-epilepsia-refractaria/

  28. Lüders HO. Protocols and outcome statistics from epilepsy surgery centres. In: Epilepsy surgery. Lüders HO, Comair YG, Editors. 5th ed. USA: Lippincott Williams & Wilkins 2016. p. 973-8.

  29. Kim R, Spencer D. Surgery for medial temporal sclerosis. In: Epilepsy surgery. Lüders HO, Comair YG, Editors. 5th ed. USA: Lippincott Williams & Wilkins 2016.p. 643-51.

  30. Meguins L, Adry R, Silva-Junior S, Araújo Filho G, Marques L. Shorter epilepsy duration is associated with better seizure outcome in temporal lobe epilepsy surgery. Arq Neuro-Psiquiatr [Internet]. 2015[citado 08/08/2018]; 73(3):212-7. Disponible en : http://www.scielo.br/scielo.php?script=sci_arttext& pid=S0004-282X2015000300212&lng=en

  31. Vickrey BG, Hays RD, Engel JJr. Outcome assessment for epilepsy surgery: the impact of measuring health-related quality of life. Ann Neurol 1995; 37(2):158-66.

  32. Engel JJr. Surgical treatment of epilepsies. New York: Raven Press; 1987.

  33. Engel JJr, Van Ness PC, Rasmussen T, Ojeman LM. Outcome with respect to epileptic seizures. In: Engel JJr, editor. Surgical treatment of epilepsies. 2 ed. New York: Raven Press; 1993. p. 609-21.

  34. Morales Chacón LM, García Maeso I, Báez Martin MM, Bender del Busto JE, García Navarro ME, Quintanal Cordero N, et al. Long-term electroclinical and employment follow up in temporal lobe epilepsy surgery. A Cuban Comprehensive Epilepsy Surgery Program. Behav Sci 2018; 8(19).




2020     |     www.medigraphic.com